Back to BAKER BROS. ADVISORS LP

NRIX
Showing 8 of 23 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in NURIX THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 4.7M shares of NRIX (NURIX THERAPEUTICS INC), worth $72.2M as of 2026-Q1. NRIX represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$72.2M

Current Shares

4.7M

Total Value Change

-$8.8M

Total Shares Change

+776,431

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
4.7M
0.0%
$72.2M0.4%$15.81
0
2025-Q4
Increased
4.7M
+20.0%
$88.4M0.5%$19.02
50
2025-Q3
Unchanged
3.9M
0.0%
$35.9M0.3%$9.28
0
2025-Q2
Unchanged
3.9M
0.0%
$44.2M0.4%$11.64
0
2025-Q1
Unchanged
3.9M
0.0%
$46.1M0.5%$12.15
0
2024-Q4
Unchanged
3.9M
0.0%
$73.1M0.8%$18.64
0
2024-Q3
Unchanged
3.9M
0.0%
$87.2M0.9%$23.05
0
2024-Q2
Unchanged
3.9M
0.0%
$81M1.0%$20.87
0

Other major holders of NRIX: FMR LLC, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used